Great conference call. And here are the details!
1)The number one highlight of the call was that the company is going to be launching their product for the cardiology market in December, two to three quarters ahead of time.
2)The company is comfortable with sales estimates of $7 to $10 million for the 4th quarter. I think they top $10 million.
3)Company is much more optimistic about revenue for next year and estimates a breakeven quarter in 2000, I'm estimating q3, way ahead of analyst estimates.
4)Asian distributors completely sold right through products sent to them showing the emerging market potential.
5)Japanese potential is huge expect approval in mid to late q1, sales in q2. I think this is what helps them get to breakeven in q3, SONO is very, very excited about Olympus their Japanese distributor.
6)ER meeting, went way beyond expectations and response was better than expected, more leads than they thought they would have.
7)Seeing much larger institutional demand for products, Mayo Clinic (ordered in q3), possibly Kaiser Permanente in 2000.
8)SONO is talking with the U.S. Military and the U.K. military for big orders for 2000.
9)$14 to $15 million a quarter is revenue breakeven, so if we hit $10 million or better in q4 you know how close we are.
10)Only four people asked questions on the call, Sandy Hollenhurst, analyst with Vector, Bruce Jacobs with Deustche Bank Alex Brown, Aaron edelheight with Sabre Value Management and Bob Stafford with Stafford Capital Management. This shows how really unknown SONO still is and how much it could go up when more people jump on.
Overall, SONO was as usual conservative, confident and impressive.
Next up Novemeber 2 big Vector/Prudential conference presentation. |
